GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD.

Autres langues Guizhou Bailing Group Pharmaceutical Co., Ltd.

Actions

002424

CNE100000PY3

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. Autres places de cotation 23/07/2026			Varia. 5j.	Varia. 1 janv.
4,460 ^CNY	+1,13%		-5,11%	+2,53%

22/06	Trois produits de Guizhou Bailing retenus pour les achats centralisés de médecine traditionnelle en Chine	MT
19/05	Guizhou Bailing Group Pharmaceutical obtient une protection de sept ans pour son spray de médecine traditionnelle chinoise	MT

Autres langues

22/06	Guizhou Bailing's Three Products Chosen for China's Centralized Procurement for Traditional Medicine
19/05	Guizhou Bailing Group Pharmaceutical Gets Seven-Year Protection Status for Traditional Chinese Drug Spray
27/04	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
27/04	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
30/12	Guizhou Bailing Group Pharmaceutical Co., Ltd.(XSEC:002424) dropped from S&P Global BMI Index
19/12	Guizhou Bailing's trading to halt to implement other risk warning
03/12	Guizhou Bailing Group Pharmaceutical's actual controller investigated for suspected rule violations
24/10/25	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
16/10/25	Guizhou Bailing's Unit Gets Nod to Trial Tangning Tongluo Tablets
22/09/25	Guizhou Bailing Group Pharmaceutical Co., Ltd.(XSEC:002424) added to S&P Global BMI Index
19/08/25	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
29/04/25	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
28/04/25	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
13/11/24	Bailing Pharma Gets Clinical Trial Approval for Diabetic Retinopathy Traditional Chinese Tablets; Shares Rise 5%
25/10/24	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
27/08/24	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
02/08/24	Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.
02/08/24	Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback announced on February 3, 2024 has closed with 20,491,812 shares, representing 1.48% for CNY 119.59 million.
01/07/24	Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.
21/05/24	Guizhou Bailing Group Pharmaceutical Co., Ltd.(XSEC:002424) dropped from FTSE All-World Index
10/05/24	Guizhou Bailing Group Pharmaceutical Co., Ltd.(XSEC:002424) dropped from S&P Global BMI Index
03/05/24	Large-Scale Equipment Renewals Seen to Raise Demand for Chinese High-End Steel Products, Trade Body Says
02/05/24	China to Tweak Production Limits for Steel as Industry Faces Low Prices, Oversupply
29/04/24	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
02/04/24	Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.